Copertina

Genetic associations of plasma proteomics with dementia subtypes and neuroimaging markers

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Ahmed M. Salih, Janek Salatzki, Yuhe Wang, Tesfamariam Akilu, Cynthia Maldonado, Masud Husain, Stefan Neubauer, Anya Topiwala, André Altmann, Zahra Raisi‐Estabragh
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease
di: Sofia Toniolo, et al.
Pubblicazione: (2024)

Tracking clinical and neuroimaging progression of Alzheimer's disease by longitudinal trajectories of plasma biomarkers
di: Frederikke Kragh Clemmensen, et al.
Pubblicazione: (2026)

Discovery of cerebrospinal fluid biomarkers for different dementias using mass spectrometry‐based proteomics
di: Marijke E. Stokkel, et al.
Pubblicazione: (2026)

Diagnostic utility of plasma p‐tau217 differs by Alzheimer's disease tau‐based subtypes
di: Seyed Hani Hojjati, et al.
Pubblicazione: (2025)

Preclinical dementia rating scores are associated with plasma phosphorylated tau‐217
di: Qi Huang, et al.
Pubblicazione: (2025)

Reduced plasma hexosylceramides in frontotemporal dementia are a biomarker of white matter integrity
di: Oana C. Marian, et al.
Pubblicazione: (2025)

Cross‐sectional study of plasma phosphorylated tau 217 in persons without dementia
di: Toni T. Saari, et al.
Pubblicazione: (2025)

Neurology and inflammatory‐associated plasma protein biomarkers linked to dementia progression, brain aging pathology
di: Noah Schweitzer, et al.
Pubblicazione: (2026)

Exploring cognitive progression subtypes in the Framingham Heart Study
di: Huitong Ding, et al.
Pubblicazione: (2024)

Clinical performance of the fully automated Lumipulse plasma p‐tau217 assay in mild cognitive impairment and mild dementia
di: Adam H. Dyer, et al.
Pubblicazione: (2025)

Clinical and neuropathological associations of plasma Aβ42/Aβ40, p‐tau217 and neurofilament light in sporadic frontotemporal dementia spectrum disorders
di: Binita Rajbanshi, et al.
Pubblicazione: (2025)

Temporal comorbidity patterns in Alzheimer's disease and vascular dementia: A population‐based observational study in UK Biobank
di: Chloe Walsh, et al.
Pubblicazione: (2026)

Deep medullary vein abnormalities associated with cognitive function and Alzheimer's disease plasma biomarkers in dementia‐free older adults: A population‐based study
di: Dejia Yin, et al.
Pubblicazione: (2026)

Speech markers of depression dimensions across cognitive status
di: Laili Soleimani, et al.
Pubblicazione: (2024)

Awareness, attitudes, and beliefs of dementia in Indonesia
di: Nicolas Farina, et al.
Pubblicazione: (2024)

Serum biomarkers as prognostic markers for Alzheimer's disease in a clinical setting
di: Steffi De Meyer, et al.
Pubblicazione: (2025)

Accuracy of pattern‐based dementia diagnostic protocols: Using longitudinal data to infer etiology of Alzheimer's disease and related dementias compared to stroke or normal aging
di: Sean A. P. Clouston, et al.
Pubblicazione: (2025)

NODDI in gray matter is a sensitive marker of aging and early AD changes
di: Xi Yu, et al.
Pubblicazione: (2024)

Exploring the relationship between melanopsin gene variants, sleep, and markers of brain health
di: Ayeisha Milligan Armstrong, et al.
Pubblicazione: (2025)

Incidence of young‐onset dementia in Italy: The Brescia register study
di: Barbara Borroni, et al.
Pubblicazione: (2024)

Stigma, isolation, and depression in Chinese and Korean American dementia caregivers
di: Xiang Qi, et al.
Pubblicazione: (2026)

Social relationships, amyloid burden, and dementia: The ARIC‐PET study
di: Renée C. Groechel, et al.
Pubblicazione: (2024)

Factors associated with knowledge in African immigrants with personal experiences of dementia
di: Manka Nkimbeng, et al.
Pubblicazione: (2024)

Racial/ethnic differences in neuropsychiatric disturbances associated with incident dementia
di: Elizabeth A. Wise, et al.
Pubblicazione: (2024)

Longitudinal changes in functional capacity in frontotemporal dementia and Alzheimer's disease
di: David Foxe, et al.
Pubblicazione: (2024)

Biological sex and bilingualism: Its impact on risk and resilience for dementia
di: Noelia Calvo, et al.
Pubblicazione: (2026)

The prodromal presentation of dementia with Lewy bodies: Application of the proposed research criteria
di: Paula Marie Loveland, et al.
Pubblicazione: (2026)

Modeling contributions of cognition and apathy to functional impairment in younger‐onset dementia
di: Samuel L. Warren, et al.
Pubblicazione: (2026)

Commentary on “It is time to share Alzheimer biomarker results in dementia with Lewy bodies”
di: John T. O'Brien
Pubblicazione: (2025)

Timely dying in dementia: Use patients' judgments and broaden the concept of suffering
di: Stanley A. Terman, et al.
Pubblicazione: (2024)

Navigating late‐stage dementia: A perspective from the Alzheimer's Association
di: Kristen Clifford, et al.
Pubblicazione: (2024)

Poor dream recall associates with Alzheimer's disease biomarkers and dementia risk
di: Darren M. Lipnicki, et al.
Pubblicazione: (2026)

Loneliness trajectories and dementia risk: Insights from the HUNT cohort study
di: Ragnhild Holmberg Aunsmo, et al.
Pubblicazione: (2025)

Autonomic dysfunction and hypothalamic atrophy in frontotemporal dementia and primary psychiatric disorders
di: Yannick S. S. Timar, et al.
Pubblicazione: (2026)

Can annual wellness visits reduce disparity in early dementia diagnosis?
di: Yong‐Fang Kuo, et al.
Pubblicazione: (2025)

Hospitalization outcomes among older adults living undiagnosed or unaware of dementia
di: Halima Amjad, et al.
Pubblicazione: (2025)

Impairments in knowledge of social norms in presymptomatic, prodromal, and symptomatic frontotemporal dementia
di: Liset de Boer, et al.
Pubblicazione: (2024)

Odor identification and progression to dementia: The role of odor characteristics and set size
di: Eva Dickmänken, et al.
Pubblicazione: (2024)

Sensory changes in preclinical, prodromal, and clinical Alzheimer's disease and related dementias
di: Willa D. Brenowitz, et al.
Pubblicazione: (2026)

Can an effective end‐of‐life intervention for advanced dementia be viewed as moral?
di: Stanley A. Terman
Pubblicazione: (2024)